Investing in Eli Lilly and Tesla for long-term growth potential is recommended.

From Nasdaq: 2024-07-15 07:45:00

Investing in growth stocks with long-term potential can lead to significant gains. Eli Lilly’s weight-loss drug, Zepbound, is capturing profits with the rise in obesity rates. Goldman Sachs predicts Eli Lilly to dominate the $130 billion obesity drug market by 2030. Tesla’s position in the EV and AI markets shows promise for growth. The company’s driverless car initiative could generate over $600 billion in revenue by 2029, driving the stock price up tenfold. Additionally, Tesla’s AI-powered robots have a potential profit opportunity of $1 trillion. Considering the growth potential in these sectors, investing in Eli Lilly and Tesla could result in lucrative returns.



Read more at Nasdaq: 2 Unstoppable Growth Stocks to Buy and Hold for the Next Decade